Targeting tRNA‐Derived Non‐Coding RNA Alleviates Diabetes‐Induced Visual Impairment through Protecting Retinal Neurovascular Unit
Advanced Science · 2025-01 · 12 (1)
DOI: 10.1002/advs.202411042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.11.2024. Verfasst von Jin Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Experimental, RNA, Untranslated. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes is a major risk factor for compromised visual health, leading to retinal vasculopathy and neuropathy, both of which are hallmarks of neurovascular unit dysfunction. Despite the critical impact of diabetic retinopathy, the precise mechanism underlying neurovascular coupling and effective strategies to suppress neurovascular dysfunction remain unclear. In this study, the up‐regulation of a tRNA‐derived stress‐induced RNA, 5′tiRNA‐His‐GTG, in response to diabetic stress is revealed. 5′tiRNA‐His‐GTG directly regulates Müller glia action and indirectly alters endothelial angiogenic effects and retinal ganglion cell (RGC) survival in vitro. Downregulation of 5′tiRNA‐His‐GTG alleviates diabetes‐induced retinal neurovascular dysfunction, characterized by reduced retinal vascular dysfunction, decreased retinal neurodegeneration, and improved visually‐guided behaviors in vivo. Mechanistically, 5′tiRNA‐His‐GTG acts as a key regulator of retinal neurovascular dysfunction, primarily by modulating arachidonic acid (AA) metabolism via the CYPs pathway. The 5′tiRNA‐His‐GTG‐CYP2E1‐19(S)‐HETE signaling axis is identified as a key driver of retinal neurovascular dysfunction. Thus, targeting 5′tiRNA‐His‐GTG presents a promising therapeutic strategy for treating vasculopathy and neuropathy associated with diabetes mellitus. Modulating this novel signaling pathway can open up new avenues for intervention in diabetic retinopathy and its related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China.
- School of Medicine, Southeast University, Nanjing, 210009, China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
- Eye Institute and Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, 200031, China.
ORCID-Profile: Biao Yan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yao, J., Yao, W., Zhu, J. Y., Liu, Y., Liu, J. H., Ji, Y. K., Ni, X. S., Mu, W., & Yan, B. (2025). Targeting tRNA‐Derived Non‐Coding RNA Alleviates Diabetes‐Induced Visual Impairment through Protecting Retinal Neurovascular Unit. Advanced Science, 12(1). https://doi.org/10.1002/advs.202411042
Vancouver
Yao J, Yao W, Zhu JY, Liu Y, Liu JH, Ji YK, et al. Targeting tRNA‐Derived Non‐Coding RNA Alleviates Diabetes‐Induced Visual Impairment through Protecting Retinal Neurovascular Unit. Advanced Science. 2025;12(1). doi:10.1002/advs.202411042
BibTeX
@article{Yao2025,
author = {Yao, Jin and Yao, Wen and Zhu, Jun-Ya and Liu, Yan and Liu, Jin-Hong and Ji, Yu-Ke and Ni, Xi-Shen and Mu, Wan and Yan, Biao},
title = {Targeting tRNA‐Derived Non‐Coding RNA Alleviates Diabetes‐Induced Visual Impairment through Protecting Retinal Neurovascular Unit},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {1},
doi = {10.1002/advs.202411042}
}
EUVIMED